SEARCH
Oxford Covid vaccine will be ready by year-end if Phase 3 trials go well: Adar Poonawalla
India Today
2020-07-22
Views
14
Description
Share / Embed
Download This Video
Report
A day after the Lancet published the first human trial data of the Covid-19 vaccine being developed by the Oxford University, Serum Institute of India CEO Adar Poonawalla said the vaccine will be ready by yearend if Phase 3 trials go well.
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://vntv.net//embed/x7v51x8" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
04:31
Anil Vij, Haryana Minister Gets Trial Dose Of COVID-19 Vaccine Covaxin; Union Health Minister On India's Vaccine Distribution Plan; Oxford Vaccine Likely By April 2021, Rs 1,000 For 2 Doses: Adar Poonawalla
03:50
Oxford COVID-19 Vaccine ‘70% Effective, Serum Institute Chief Adar Poonawalla Says India Could Give Nod By Year-End
02:09
Coronavirus Vaccine Update: Adar Poonawalla ने बताया, कब उपलब्ध होगा टीका | वनइंडिया हिंदी
04:03
Sputnik V, Russia's COVID-19 Vaccine Arrives In India For Phase 2/3 Trials, Watch Video; Govt Pins Hope On Five Coronavirus Vaccines Under Trial In India
10:24
Key researcher in AstraZeneca's Oxford vaccine breaks down trials data
02:18
Oxford Vaccine Serum Institute Halts Coronavirus Vaccine Trials In India | Oneindia Malayslam
03:13
New COVID-19 Vaccine from Oxford Begins Phase 1-2 Clinical Trials
00:43
Serum Institute to conduct Phase 2, 3 clinical trials of Oxford University Covid vaccine
03:13
New COVID-19 Vaccine from Oxford Begins Phase 1-2 Clinical Trials
03:13
New COVID-19 Vaccine from Oxford Begins Phase 1-2 Clinical Trials
01:29
Covaxin, Bharat Biotech's Coronavirus Vaccine Cleared For Phase 3 Trials || Oneindia Telugu
01:54
Scientists at Oxford University share promising news on coronavirus vaccine trials